Air pollution has caused 40% higher deaths than that of COVID-19, in the past two years;
making it a most serious global concern with the exponential increase in health implications …

The present invention relates to, inter alia, pharmaceutical compositions comprising EPA
and one or more cardiovascular agents, and to therapeutic methods for treating various …

In various embodiments, the present invention provides methods of treating and/or
preventing cardiovascular-related disease and, in particular, a method of reducing …

First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
48745474&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

Related US Application Data Continuation of application No. 15/273,430, filed on Sep. 22,
2016, now Pat. No. 10,220,013, which is a continuation of application No. 14/704,329, filed …

6,331,568 B1 6,362,236 B1 6,368,621 B1 6,383,482 B1 6,384,077 B1 6,440,961 B1
6,479,544 B1 6,482,421 B2 6,531,150 B1 6,555,700 B1 6,596,766 B1 6,620,821 B2 …

The present invention relates to, inter alia, pharmaceutical compositions comprising a
polyunsaturated fatty acid and to methods of using the same to treat or prevent …

In various embodiments, the present invention provides methods of reducing the risk of a
cardiovascular event in a subject on statin therapy and, in particular, a method of reducing …

In various embodiments, the present disclosure provides compositions and methods for
treating and/or preventing cardiovascular-related diseases in subject in need thereof having …

The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with
ethyl eicosapentaenoate.